These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19681336)

  • 1. Comparative effectiveness research: get to know the term.
    Elston DM
    Cutis; 2009 Jun; 83(6):287-8. PubMed ID: 19681336
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness research.
    Pentecost MJ
    J Am Coll Radiol; 2009 Aug; 6(8):547-8. PubMed ID: 19643380
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. High-value, cost-conscious health care.
    Ann Intern Med; 2011 Feb; 154(3):I30. PubMed ID: 21282690
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of support for cost-utility analysis in the health care reform law: a case of ignorance or political posturing?
    Shaw JW
    Clin Ther; 2010 Jun; 32(6):1091-2. PubMed ID: 20637963
    [No Abstract]   [Full Text] [Related]  

  • 7. "Value for money": use with care.
    Gusmano MK; Callahan D
    Ann Intern Med; 2011 Feb; 154(3):207-8. PubMed ID: 21282702
    [No Abstract]   [Full Text] [Related]  

  • 8. Practice-based outcomes research: crucial, feasible, and neglected.
    Avorn J
    Pediatrics; 1996 Jan; 97(1):113-4. PubMed ID: 8545203
    [No Abstract]   [Full Text] [Related]  

  • 9. US drug trials said to ignore gender differences.
    Watson T
    Nature; 1992 Nov; 360(6399):6. PubMed ID: 1436074
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 11. What works? What does it cost? Comparative studies will drive decisions in health care reform.
    Assael LA
    J Oral Maxillofac Surg; 2010 Jan; 68(1):1-2. PubMed ID: 20006146
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodological issues in comparative effectiveness research: clinical trials.
    Peduzzi P; Kyriakides T; O'Connor TZ; Guarino P; Warren SR; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e8-15. PubMed ID: 21184867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How might cost effectiveness, quality of life, and outcomes data be used by government regulators?
    Gatty B
    Hosp Formul; 1994 Jan; 29(1):70, 69. PubMed ID: 10131268
    [No Abstract]   [Full Text] [Related]  

  • 14. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 15. Untying the Gordian knot.
    Su F; Zuppa AF; Adamson PC
    Anesth Analg; 2007 Apr; 104(4):993; author reply 993-4. PubMed ID: 17377125
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase 0 clinical trials in oncology: an exploratory methodology for constructing a study with patients undergoing surgery for metastatic disease.
    Pocard M; Soria JC; Aldaz-Carroll L; Bellet D
    J Clin Oncol; 2010 Oct; 28(30):4551-3. PubMed ID: 20837954
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA's critique of the anturane reinfarction trial.
    Temple R; Pledger GW
    N Engl J Med; 1980 Dec; 303(25):1488-92. PubMed ID: 7432418
    [No Abstract]   [Full Text] [Related]  

  • 18. Healthcare reform and comparative effectiveness research. New approach targeted to be more efficient and cost effective.
    Ferman JH
    Healthc Exec; 2010; 25(2):66, 68-70. PubMed ID: 20349767
    [No Abstract]   [Full Text] [Related]  

  • 19. 'Cure acceleration' funds woven into health reform legislation.
    Wadman M
    Nat Med; 2010 Feb; 16(2):135. PubMed ID: 20134439
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.